How to buy Pasithea Therapeutics (KTTA) shares in the UK

Learn how to easily invest in Pasithea Therapeutics shares.

Pasithea Therapeutics Corp. (KTTA) is a leading biotechnology business based in the US. It opened the day at $2.52 after a previous close of $2.58. During the day the price has varied from a low of $2.2 to a high of $2.52. The latest price was $2.28 (25 minute delay). Pasithea Therapeutics is listed on the NASDAQ and employs 1 staff. All prices are listed in US Dollars.

How to buy shares in Pasithea Therapeutics

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: KTTA in this case.
  5. Research Pasithea Therapeutics shares. The platform should provide the latest information available.
  6. Buy your Pasithea Therapeutics shares. It's that simple.
The whole process can take as little as 15 minutes.

Pasithea Therapeutics share price (NASDAQ:KTTA)

Use our graph to track the performance of KTTA stocks over time.

Pasithea Therapeutics shares at a glance

Information last updated 2021-12-10.
Open$2.52
High$2.52
Low$2.2
Close$2.28
Previous close$2.58
Change$-0.3
Change %-11.6279%
Volume1,671,758
Information last updated 2022-01-13.
52-week range$1.39 - $5.6
50-day moving average$2.3976
200-day moving average$2.578
Wall St. target price$3.25
Dividend yieldN/A (0%)
Earnings per share (TTM)$-0.347
Promoted
eToro Free Stocks

Invest in Pasithea Therapeutics shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes
Capital at risk

Fees for buying 100x Pasithea Therapeutics shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $50 £0.84
£167.91 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £0.42
£167.50 total
Capital at risk
Stake logo £0 £50 £0.84
£167.91 total
Capital at risk
IG Share Dealing logo £0 £250 £8.20
£175.28 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £13.62
£180.70 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £10.50
£177.57 total
Capital at risk
Fineco logo £0 No minimum £1.67
£168.75 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £11.59
£178.67 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Pasithea Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value $1.247
Market capitalisation $32.8 million

TTM: trailing 12 months

Pasithea Therapeutics share dividends

We're not expecting Pasithea Therapeutics to pay a dividend over the next 12 months. Typically it's companies that have been around for longer that pay dividends (Pasithea Therapeutics had its IPO on 14 September 2021). However, you can browse other dividend-paying shares in our guide.

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Shares similar to Pasithea Therapeutics

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site